Recently, the interaction between CYP2A13 and ABCB1was reported to be closely associated with lung cancer, and CYP2A13 was identified as a potential critical metabolic enzyme gene in the carcinogenesis of lung cancer [46, 47]. The gene discussed is CYP2A13; the disease is lung carcinoma.